Akebia Therapeutics Inc (AKBA)
Net Income Growth
-3706.48%
Quarterly · Period ending:
AKBA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-3706.48%period ending
Latest reported-3706.48%period ending
AKBA Quarterly Net Income YoY % (-82.62% → -3706.48%)
Year-over-year change
High-resolution chart · PNG
AKBA net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -3,706.4777% | |
| -248.1348% | |
| 46.3077% | |
| 102.6947% | |
| 102.8781% | |
| 133.9839% | |
| -3,814.0065% | |
| -38.3049% | |
| 23.183% | |
| 33.0816% | |
| 108.1303% | |
| 73.2161% | |
| -137.9368% | |
| 56.944% | |
| 89.1901% | |
| 9.1495% | |
| 135.4645% | |
| 10.2889% | |
| 19.6989% | |
| 0.6921% | |
| 52.7525% | |
| -14.5406% | |
| 7.9199% | |
| -9.8452% | |
| -202.1334% | |
| 16.1196% | |
| -6.9175% | |
| -109.5635% | |
| -70.7417% | |
| -209.2536% | |
| -819.6254% | |
| -12.5919% | |
| -58.3279% | |
| 47.4261% | |
| 132.4336% | |
| 36.284% | |
| 39.8586% | |
| -72.6607% | |
| -90.6733% | |
| -86.4339% | |
| -234.7273% | |
| -141.2155% | |
| -91.4851% | |
| -108.3333% | |
| -40.3064% | |
| -10.2906% | |
| -74.339% | |
| -148.0892% | |
| -169.1577% | |
| -1,461.7477% | |
| -82.6221% |